Effects of RAS on Gait in PD Patients With DBS
Parkinson Disease
About this trial
This is an interventional treatment trial for Parkinson Disease focused on measuring Parkinson disease, Deep brain stimulation, Rhythmic auditory stimulation
Eligibility Criteria
Inclusion Criteria: Patients diagnosed with Parkinson disease (PD) (and) PD patients who implanted Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) with PerceptTM PC Exclusion Criteria: Inability or unwillingness to follow directions for study procedures
Sites / Locations
- Johns Hopkins School of MedicineRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
No Intervention
Pre RAS
During RAS
Post RAS
After a 10-minute washout period, participants will receive the participants' optimized stimulation. The participants will undergo assessments to measure gait parameters and patterns during stimulation ON and OFF (Pre-RAS) using the 10-meter walk (during a 2-minute walk) and MDS-UPDRS-III rating scale. Electrophysiological activity (e.g., local field potentials, LFPs) will be collected before assessments.
The participants will walk to the metronome beats for four minutes (2 minutes for the same beats as baseline cadence and 2 minutes for 10% faster than baseline cadence) (RAS), and the participants' gait parameters will be recorded. Electrophysiological activity (e.g., local field potentials, LFPs) will be collected.
The same assessment as the Pre-RAS will be conducted (Post-RAS).